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In diabetes mellitus, pituitary adenylate cyclase-activating polypeptide (PACAP) has insulinotropic and
glucose-lowering properties. We previously demonstrated that transgenic mice overexpressing PACAP in
pancreatic β-cells (PACAP-Tg) show attenuated pancreatic islet hyperplasia and hyperinsulinemia in type
2 diabetic models. To explore the underlying mechanisms, here we crossed PACAP-Tg mice with lethal
yellow agouti (KKAy) diabetic mice, and performed gene chip analysis of laser capture microdissected
pancreatic islets from four F1 offspring genotypes (wild-type, PACAP-Tg, KKAy, and PACAP-Tg:KKAy). We
identiﬁed 1371 probes with 416-fold differences between at least one pair of genotypes, and classiﬁed
the probes into ﬁve clusters with characteristic expression patterns. Gene ontology enrichment analysis
showed that genes involved in the terms ribosome and intracellular organelles such as ribonucleoprotein
complex, mitochondrion, and chromosome organization were signiﬁcantly enriched in clusters char-
acterized by up-regulated genes in PACAP-Tg:KKAy mice compared with KKAy mice. These results may
provide insight into the mechanisms of diabetes that accompany islet hyperplasia and amelioration by
PACAP.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Pancreatic islet β-cell mass increases in obese-diabetic rodent
models including ob/ob mice [1], db/db mice [2], lethal yellow
agouti (KKAy) mice [3,4], and high-fat diet-fed mice [5], comparedr B.V. This is an open access article
l yellow agouti diabetic mice;
tide; PACAP-Tg mice, trans-
ls
lecular Neuropharmacology,
University, 1-6 Yamadaoka,
hintani),with non-obese controls. However, islet β-cell hyperplasia is not
necessarily associated with increased insulin release to compen-
sate for increased insulin demand after overt diabetes [5–7].
Therefore, increasing β-cell function and mass, and preventing β-
cell aggravation in type 2 diabetes, will greatly improve currently
available therapies as well as future cell-based therapies involving
pancreatic β-cell replenishment.
Pituitary adenylate cyclase-activating polypeptide (PACAP), a
glucoincretin peptide member that also includes glucagon-like
peptide 1, enhances glucose-induced insulin secretion and par-
tially mediates dipeptidyl peptidase-4 inhibition-induced insulin
response [8–11]. We previously generated transgenic mice over-
expressing PACAP in pancreatic β cells under the control of human
insulin promoter (PACAP-Tg), and reported that PACAP-Tg miceunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Fig. 1. Differential gene expression in pancreatic islets from PACAP-Tg, KKAy, and PACAP-Tg:KKAy mice compared with wild-type mice. (A) mRNA expression levels. Colored
bars represent the ratio of hybridization measurements as logarithm of fold-change vs. wild-type mice, according to the scale shown. Genes were classiﬁed into ﬁve clusters
using the k-means clustering algorithm. (B) Gene expression patterns for clusters 1–5 in PACAP-Tg, KKAy, and PACAP-Tg:KKAy mice. Values represent the ratio of hy-
bridization measurements as logarithm of fold-change vs. wild-type mice.
Table 1
GO pathway annotation terms enriched in each gene cluster.
Term Benjamini P value
Cluster 1
Ribosome
Ribosome 2.9E11
Structural constituent of ribosome 1.9E08
Translation 7.2E07
Ribonucleoprotein complex 7.3E07
Non-membrane-bounded organelle 2.2E06
Intracellular non-membrane-bounded organelle 2.2E06
Mitochondrion
Mitochondrial inner membrane 3.3E02
Organelle inner membrane 4.4E02
Cluster 2
Ribosome
Structural constituent of ribosome 1.7E02
Ribosome 3.2E02
Ribonucleoprotein complex 4.8E02
Chromosome
Chromosome 3.0E02
Nucleosome 3.9E02
Chromatin assembly or disassembly 4.3E02
Chromatin organization 4.3E02
Chromosome organization 4.8E02
Mitochondrion
Mitochondrion 4.4E02
GO pathway annotation terms enriched in each gene cluster were determined by
functional annotation analysis. P values represent Benjamini-corrected P values.
After Benjamini correction, no annotation term was signiﬁcantly enriched in
clusters 3–5.
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normalized hyperplasia of pancreatic islets, and attenuated hy-
perinsulinemia in mouse models of type 2 diabetes such as KKAy
mice and high-fat diet feeding [3,4,13,14]. Furthermore, weobserved that attenuated islet hyperplasia in PACAP-Tg:KKAy mice
is due to a decrease in islet density, and not size [3].
To determine the underlying mechanisms, here we examine
gene expression proﬁles in hyperplastic islets and those sup-
pressed by PACAP overexpression. RNA extraction from the pan-
creas is challenging owing to high RNase levels and diffuse islet
distribution: although islets are scattered throughout the pan-
creas, they occupy only a few percent area of the total organ. Thus,
RNA extraction methods such as laser capture microdissection are
crucial for isolating islet RNA from intact pancreatic tissue [15].
In the present study, we crossed PACAP-Tg mice with KKAy
mice, and performed gene chip analysis of laser capture micro-
dissected pancreatic islets from four F1 offspring genotypes (wild-
type, PACAP-Tg, KKAy, and PACAP-Tg:KKAy), coupled to Gene On-
tology (GO) term enrichment analysis.2. Materials and methods
2.1. Animals
All animal care and handling procedures were approved by the
Animal Care and Use Committee of the Graduate School of Phar-
maceutical Sciences, Osaka University. Generation of PACAP-Tg
mice has previously been reported [12]. Male KKAy mice (Japan
CLEA, Tokyo, Japan) were crossed with female PACAP-Tg mice on a
C57BL/6 J background to produce F1 offspring with four male F1
genotypes (wild-type, PACAP-Tg, KKAy, and PACAP-Tg:KKAy) on a
C57BL/6 J and the original Japanese KK strain hybrid background
as described previously [4]. Mice were housed in a temperature-,
humidity-, and light-controlled room with a 12-h light/12-h dark
cycle (light on at 8 a.m.) and allowed free access to water and food
(CMF, 369 kcal/100 g, Oriental Yeast Co. Ltd., Tokyo, Japan).
Table 2
Genes enriched for the GO term ribosome and its related terms.
Gene symbol Gene title PACAP-Tg KKAy PACAP-
Tg: KKAy
(log2(fold) vs. wild-type)
Cluster 1
MTAP7D1 Microtubule-associated protein
7 domain containing 1
0.7 6.2 1.0
CHD4 Chromodomain helicase DNA
binding protein 4
0.1 6.1 1.2
UBXN6 UBX domain protein 6 0.2 5.5 0.8
SMARCC1 SWI/SNF related, matrix asso-
ciated, actin dependent reg-
ulator of chromatin, subfamily c,
member 1
1.0 5.4 0.1
BAZ1B Bromodomain adjacent to zinc
ﬁnger domain, 1B
0.6 5.0 0.8
MRPS34 Mitochondrial ribosomal pro-
tein S34
0.2 4.8 1.4
RPS19 Ribosomal protein S19 1.0 4.6 1.5
VIL1 Villin 1 0.3 4.5 2.1
RPS8 Ribosomal protein S8 0.7 4.4 2.3
H2AFV H2A histone family, member V 0.3 4.4 2.5
NCL Nucleolin 2.4 3.9 0.8
GAR1 GAR1 ribonucleoprotein homo-
log (yeast)
0.1 3.6 3.0
NUP50 Nucleoporin 50 2.2 3.6 3.0
ACTR3 ARP3 actin-related protein 3 1.0 3.5 1.8
KIF20A Kinesin family member 20A 0.1 3.3 1.2
PARP2 Poly (ADP-ribose) polymerase
family, member 2
0.8 3.2 2.3
EPRS Glutamyl-prolyl-tRNA
synthetase
0.4 3.1 2.4
TUBB5 Tubulin, beta 5 class I 0.3 3.1 2.9
RPS10 Ribosomal protein S10 0.5 3.1 3.6
RPS27 Ribosomal protein S27 0.6 3.0 2.2
DYNLRB1 Dynein light chain roadblock-
type 1
1.8 3.0 1.8
FCF1 rRNA-processing protein FCF1
homolog
2.3 2.8 3.3
DYNLL1 Dynein light chain LC8-type 1 0.6 2.8 3.4
RPL10 Ribosomal protein L10 0.3 2.7 2.5
RPS26 Ribosomal protein S26 0.1 2.7 2.9
EEF1A1 Eukaryotic translation elonga-
tion factor 1 alpha 1
0.5 2.5 3.0
Cluster 2
RPL7 Ribosomal protein L7 0.5 2.8 4.6
RPS3A Ribosomal protein S3A 1.1 2.6 4.0
RPLP0 Ribosomal protein, large, P0 1.0 2.6 4.2
UBB Ubiquitin B 1.4 1.9 3.2
SNRPE Small nuclear ribonucleo-
protein E
0.8 1.9 3.8
RPS18 Ribosomal protein S18 0.9 1.4 4.2
RPS4X Ribosomal protein S4, X-linked 1.0 1.0 4.1
HNRNPA2B1 Heterogeneous nuclear ribonu-
cleoprotein A2/B1
1.3 0.1 4.6
MRPL35 Mitochondrial ribosomal pro-
tein L35
1.3 0.4 5.1
Genes enriched for the GO pathway annotation terms, ribosome and its related
terms (translation, ribonucleoprotein complex, and non-membrane-bounded or-
ganelle). Expression levels are indicated as logarithm of fold-change vs. wild-type
mice. Representative genes with the largest changes are shown.
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Pancreata were removed from 15-week-old mice, and their sec-
tions were adhered to non-coated glass slides, ﬁxed by treatment
with 75% ethanol for 30 s at 18 °C, and then dehydrated. The Pix-
Cell IIe Laser Capture Microdissection System (Arcturus, Mountain
View, CA, USA) was used to isolate 50–70 islet pieces that were laser
captured to CapSur (Arcturus). Cell homogeneity was conﬁrmed
microscopically prior to processing for RNA extraction. Total RNAwassubsequently extracted using the Pico Pure RNA Isolation kit
(Arcturus) according to the manufacturer's protocols.
2.3. RNA ampliﬁcation, oligonucleotide microarrays, and real-time
quantitative PCR
RNA ampliﬁcation and oligonucleotide microarrays were per-
formed as described previously [16–18], but with several mod-
iﬁcations. First-round RNA ampliﬁcation was performed using the
RiboAmp OA RNA Ampliﬁcation kit (Arcturus) to linearly amplify
anti-sense RNA, according to the manufacturer's instructions.
Samples with ampliﬁed anti-sense RNA products 4200 ng were
then subjected to second-round ampliﬁcation. cDNA was synthe-
sized using Superscript II reverse transcriptase (Invitrogen, Carls-
bad, CA, USA), and biotin-labeled anti-sense RNA prepared by the
Enzo High Yield RNA Transcript Labeling kit (Enzo Diagnostics,
Farmingdale, NY, USA). The resulting anti-sense RNAs were hy-
bridized to GeneChip Murine Genome U74v.2 oligonucleotide ar-
rays (Affymetrix, Santa Clara, CA, USA) using standard methods
(n¼1 per genotype). Image ﬁles were processed using the Mi-
croarray Analysis Suite software (Affymetrix).
Real-time quantitative PCR was performed using ampliﬁed RNA
from laser-captured islet cells (n¼3 per genotype), Superscript II
reverse transcriptase (Invitrogen), random hexamers, and DyNA-
mo SYBR Green qPCR kit (Finnzymes, Espoo, Finland). The fol-
lowing primers were used for PCR: mouse PACAP, forward, 5′-AGA
AGA CGA GGC TTA CGA CCA G-3′, reverse, 5′-TTT CTT GAC AGC CAT
TTG TTT TCG G-3′; mouse GAPDH, forward, 5′-CTC ATG ACC ACA
GTC CAT GC-3′, reverse, 5′-CAC ATT GGG GGT AGG AAC AC-3′.
GAPDH mRNA was ampliﬁed as a control.
2.4. Microarray data analysis
MicroArray Suite 5.0 (MAS5; Affymetrix) was used for background
correction, algorithm normalization, and intensity log transforms. The
signal intensity for each probe in wild-type mice was subtracted from
each intensity value in the other genotypes, then all probes with
maximum minus minimum values o16-fold change were removed,
resulting in selection of 1371 probes. Using the k-means clustering
algorithm, these genes were classiﬁed into ﬁve clusters.
Functional enrichment analysis of the gene clusters was based
on GO pathway annotation terms, with P values o0.05 considered
statistically signiﬁcant.3. Results
3.1. Gene expression proﬁles in pancreatic islets from PACAP-Tg,
KKAy, and PACAP-Tg:KKAy mice
We performed laser capture microdissection to extract total
RNA from pancreatic islet tissue for gene expression analysis of the
four mouse genotypes. We subsequently ampliﬁed the RNA by two
rounds of T7 polymerase-based linear ampliﬁcation, obtaining
enough biotin-labeled anti-sense RNA samples to perform oligo-
nucleotide microarray assays. To determine if the ampliﬁed RNA
was suitable for microarray assays, we examined mRNA expression
levels of the PACAP gene (Adcyap1), and observed signiﬁcantly
overexpressed mRNA in PACAP-Tg and PACAP-Tg:KKAy mice but
not wild-type or KKAy mice (3.4-fold higher in PACAP-Tg:KKAy vs.
PACAP-Tg; wild-type and KKAy, under the detection levels).
Among the approximately 12,000 genes represented on the oli-
gonucleotide array, 1371 probes with hybridization signal ratios 416
(16-fold change between at least one pair of genotypes) were selected,
and regarded as differentially expressed genes (Supplementary Ta-
ble 1). Using the k-means clustering algorithm, these genes were
Table 3
Genes enriched for the GO terms mitochondrion, chromosome, and their related terms.
Gene symbol Gene title PACAP-Tg KKAy PACAP-Tg: KKAy
(log2(fold) vs. wild-type)
Mitochondrion and related terms
Cluster 1
COX6A1 Cytochrome c oxidase, subunit VI a, polypeptide 1 1.0 4.7 3.4
MCART1 Mitochondrial carrier triple repeat 1 0.1 4.6 0.9
TIMM8A1 translocase of inner mitochondrial membrane 8 homolog a1 (yeast) 0.4 3.3 1.3
SLC25A39 Solute carrier family 25, member 39 0.4 3.1 1.4
MDH2 Malate dehydrogenase 2, NAD (mitochondrial) 0.1 2.7 2.0
Cluster 2
ACAA2 Acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-oxoacyl-coenzyme A thiolase) 1.1 2.4 3.9
PARK7 Parkinson disease (autosomal recessive, early onset) 7 1.8 2.3 2.9
ALDH9A1 Aldehyde dehydrogenase 9, subfamily A1 2.2 1.7 4.2
TOMM20 Translocase of outer mitochondrial membrane 20 homolog (yeast) 1.1 1.2 3.1
NDUFB5 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5 1.7 0.7 6.0
ACAA1B Acetyl-coenzyme A acyltransferase 1B 0.0 0.3 4.3
COX7C Cytochrome c oxidase subunit 7C, mitochondrial-like 0.7 0.2 4.8
Chromosome and related terms
Cluster 2
SMC4 structural maintenance of chromosomes 4 0.7 1.5 3.6
HIST1H2AB histone H2A type 1-like 1.6 1.5 3.1
RBM14 RNA binding motif protein 14 0.4 1.4 3.0
CREBBP CREB binding protein 2.4 0.7 3.5
KLF1 Kruppel-like factor 1 (erythroid) 0.0 0.6 3.5
H3F3A H3 histone, family 3A 1.8 0.5 2.8
MKI67 antigen identiﬁed by monoclonal antibody Ki 67 2.6 0.5 6.8
H2AFZ H2A histone family, member Z 1.9 0.8 4.1
TOP1 topoisomerase (DNA) I 2.1 1.4 4.9
PCNA proliferating cell nuclear antigen 0.6 2.4 5.9
Genes enriched for the GO pathway annotation terms, mitochondrion and organelle inner membrane, and chromosome, nucleosome, chromatin assembly or disassembly, chromatin
organization, and chromosome organization. Expression levels are indicated as logarithm of fold-change vs. wild-type mice. Representative genes with the largest changes are shown.
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decreased expression in KKAy mice, which recovered in PACAP-Tg:
KKAy mice. Cluster 2 included genes with slightly reduced expression
in KKAymice but prominently increased expression in PACAP-Tg:KKAy
mice. Clusters 3–5 included genes with higher expression in KKAy
mice than PACAP-Tg:KKAy mice, albeit at different expression levels,
being higher in cluster 3 and lower in cluster 5 (Fig. 1B).
3.2. GO enrichment analysis of selected genes
Next, we performed GO enrichment analysis for the selected
genes, and identiﬁed signiﬁcantly enriched annotation terms for
clusters 1 and 2 (Tables 1–3). The most signiﬁcantly enriched term
was ribosome and its related terms, including translation and non-
membrane-bounded organelle (Tables 1 and 2). The term mi-
tochondrion and its related terms, such as mitochondrial inner
membrane, were also enriched for both clusters 1 and 2
(Tables 1 and 3). The term chromosome and its related terms,
including nucleosome, chromatin assembly or disassembly, chro-
matin organization, and chromosome organization were enriched
in cluster 2 (Tables 1 and 3).4. Discussion
PACAP enhances glucose-induced insulin secretion and par-
tially mediates dipeptidyl peptidase-4 inhibition-induced insulin
response [8–11]. Moreover, the longitudinal effect of PACAP on
islets, including regulation of β-cell mass and function, have been
addressed. Our previously generated PACAP-Tg mice show ame-
liorated streptozotocin-induced type 1 diabetes [12], normalized
hyperplasia of pancreatic islets, and attenuated hyperinsulinemia
in mouse models of type 2 diabetes [3,4,13,14]. In ob/ob and db/dbmice [2], total islet volume increases were due to an increase in
mean islet mass, but not number [1,2], while we observed that
attenuated islet hyperplasia in PACAP-Tg:KKAy mice is due to a
decrease in the density of both hypertrophied islets and very small
islets [3,4]. Currently available medications aim to decrease glu-
cose levels by improving insulin secretion in remaining β cells,
improving insulin activity in target tissues, or replacing missing
insulin [7,19,20]. Thus, increasing β-cell function and mass, and
preventing β-cell aggravation in type 2 diabetes will greatly im-
prove currently available therapies. In the present study, we per-
formed comparative gene expression analysis in four mouse gen-
otypes: wild-type and PACAP-Tg with or without KKAy. Because of
high RNase quantities, the diffuse distribution of pancreatic islets,
and possible alteration of gene expression during collagenase-
based procedures for islet isolation, we collected islet tissue from
the pancreas using laser capture microdissection, which is crucial
for isolating islet RNA from intact pancreatic tissue [15]. The ob-
tained total RNA was successfully ampliﬁed, labeled, and subjected
to oligonucleotide microarray assays.
Real-time quantitative PCR revealed overexpression of PACAP
mRNA in pancreatic islets in PACAP-Tg mice and 3.4-fold higher
levels of PACAP mRNA in PACAP-Tg:KKAy mice as compared with
PACAP-Tg mice. We previously showed that plasma insulin levels
were signiﬁcantly elevated in PACAP-Tg:KKAymice compared with
PACAP-Tg mice (at 17 weeks of age, PACAP-Tg:KKAy mice,
92716 ng/ml; PACAP-Tg mice, 3.3870.74 ng/ml) [4], suggesting a
signiﬁcant activation of the insulin promoter in PACAP-Tg:KKAy
mice. This may be a reason for the enhanced overexpression of
PACAP mRNA in PACAP-Tg:KKAy mice as compared with PACAP-Tg
mice because PACAP is overexpressed under the control of the β-
cell-speciﬁc insulin promoter in these mice.
Under the present experimental condition, PACAP mRNA levels
were below the detection levels in wild-type and KKAy mice,
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creatic islets in these mice. Previously, we observed slight PACAP
immunoreactivity in pancreatic islets of wild-type mice, whereas
an intense immunoreactivity was observed in PACAP-Tg mice [12].
In addition, there are several reports that demonstrate the pre-
sence of PACAP in pancreatic islets [8,9].
In the present microarray analysis, we set a threshold for dif-
ferential expression at 16-fold. This threshold point is high, but
reﬂects the high degree of expression variance among the geno-
types, which may depend on almost homogenous islet tissue
collection by laser capture microdissection and a near-linear RNA
ampliﬁcation protocol. There is a limitation to our present study:
we analyzed microarray data from a single mouse per genotype. To
overcome this, we set the differential expression threshold at a
relatively high point but it is possible that the data are biased
because of the genetic background of each mouse, and thus genes
with more subtle differential expression changes may not have
been identiﬁed. Another limitation is that we isolated RNA from
pancreatic islets which consist of several endocrine cells including
not only β cells but also α cells, δ cells and others. Although we
previously showed that insulin-positive and glucagon-positive
areas and the percentage of inﬁltrated islets were not signiﬁcantly
different between PACAP-Tg:KKAy and KKAy mice [3], we can not
exclude the possibility that the observed changes of gene ex-
pression are also reﬂected by changes in the proportion of the cell
types.
GO enrichment analysis of the genes classiﬁed in the ﬁve
clusters showed signiﬁcantly enriched terms for clusters 1 and
2 only. These two clusters contain genes with signiﬁcantly in-
creased expression in PACAP-Tg:KKAy mice compared with KKAy
mice, while clusters 3–5 contained genes with the opposite
changes: decreased expression in PACAP-Tg:KKAy mice compared
with KKAy mice. For clusters 1 and 2, genes in the annotated
terms, ribosome and mitochondrion and their related terms were
signiﬁcantly enriched. This may suggest that ribosomal-dependent
translation and mitochondrion-dependent cellular processes are
involved in PACAP transgene-dependent amelioration of KKAy
diabetic islet phenotypes [3,4,13]. In addition, genes involved in
the annotated term chromosome and its related terms were en-
riched in cluster 2. As these genes were speciﬁcally up-regulated
in PACAP-Tg:KKAy mice, it may be possible that the effects of PA-
CAP overexpression on KKAy mice, such as attenuation of hyper-
plasia and hypertrophy in KKAy islets [3,4], are mediated at least
partially by gene transcriptional control.
Gene transcriptome analyses have been performed in whole
pancreatic islets, cultured β-cell lines, and isolated β cells by ﬂow
cytometry-based sorting using real-time PCR, microarrays, and
more recently RNA sequencing analysis [21]. In addition, genome-
wide association studies have identiﬁed over 60 loci associated
with type 2 diabetes [22]. Nevertheless, causal variants for dia-
betes pathogenesis remain largely unknown, and therefore a
“missing heritability” problem remains.
In conclusion, our present observations suggest that mechan-
isms involving ribosomal and chromatin organization, and mi-
tochondrial function are relevant to the pathomechanism of islet
hyperplasia and PACAP amelioration, and may provide insight into
the preservation of β-cell function during type 2 diabetes
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